| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
51,081 |
42,605 |
$7.76M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
53,459 |
47,309 |
$7.75M |
| 71045 |
Radiologic examination, chest; single view |
22,073 |
18,707 |
$2.85M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
16,706 |
13,755 |
$2.30M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,931 |
1,455 |
$1.85M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
24,289 |
19,786 |
$1.64M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,723 |
8,756 |
$1.47M |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
16,427 |
14,586 |
$1.15M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,863 |
2,393 |
$1.00M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
8,359 |
3,072 |
$852K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
19,875 |
15,728 |
$786K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
9,259 |
3,452 |
$778K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
9,839 |
8,788 |
$768K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
19,560 |
16,415 |
$680K |
| 99218 |
|
1,214 |
666 |
$592K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13,033 |
11,412 |
$548K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,881 |
4,725 |
$542K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
15,859 |
12,874 |
$531K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
495 |
385 |
$513K |
| 71046 |
Radiologic examination, chest; 2 views |
4,221 |
3,639 |
$380K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
53,316 |
43,551 |
$284K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
2,607 |
2,453 |
$275K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,945 |
2,002 |
$251K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,998 |
2,785 |
$228K |
| 80053 |
Comprehensive metabolic panel |
28,080 |
23,054 |
$219K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,710 |
1,935 |
$185K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,448 |
3,644 |
$160K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,950 |
3,410 |
$133K |
| 99221 |
|
220 |
119 |
$125K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
727 |
362 |
$125K |
| 84484 |
|
13,900 |
10,255 |
$111K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,895 |
1,361 |
$102K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
21,018 |
17,405 |
$99K |
| 81025 |
|
16,429 |
13,993 |
$95K |
| 87634 |
|
1,572 |
1,445 |
$87K |
| 36415 |
Collection of venous blood by venipuncture |
26,730 |
22,581 |
$82K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,492 |
2,930 |
$77K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
49 |
42 |
$75K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
700 |
600 |
$72K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,016 |
4,180 |
$65K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,205 |
2,026 |
$62K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,416 |
1,017 |
$60K |
| H2011 |
Crisis intervention service, per 15 minutes |
684 |
559 |
$59K |
| 81001 |
|
24,898 |
20,974 |
$55K |
| 83690 |
|
13,530 |
11,254 |
$49K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,715 |
1,358 |
$47K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,504 |
476 |
$42K |
| 87430 |
|
4,730 |
4,187 |
$41K |
| 80076 |
|
9,090 |
7,640 |
$40K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
488 |
434 |
$32K |
| Q3014 |
Telehealth originating site facility fee |
741 |
563 |
$31K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,308 |
1,724 |
$27K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
141 |
102 |
$26K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,554 |
1,237 |
$23K |
| 83735 |
|
5,374 |
4,368 |
$21K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
773 |
428 |
$20K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,903 |
3,246 |
$20K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
119 |
90 |
$19K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
131 |
122 |
$19K |
| 80061 |
Lipid panel |
1,966 |
1,831 |
$18K |
| 97162 |
|
221 |
177 |
$16K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
727 |
699 |
$16K |
| 85610 |
|
7,111 |
4,546 |
$14K |
| 83880 |
|
706 |
606 |
$14K |
| 11043 |
|
23 |
12 |
$14K |
| 87081 |
|
3,340 |
2,940 |
$13K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
568 |
440 |
$11K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
568 |
440 |
$11K |
| 83605 |
|
2,170 |
1,603 |
$11K |
| 87631 |
|
96 |
86 |
$11K |
| 80050 |
General health panel |
81 |
77 |
$10K |
| 81003 |
|
5,729 |
4,910 |
$9K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
17 |
17 |
$8K |
| 87807 |
|
1,058 |
908 |
$7K |
| 97163 |
|
95 |
84 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
344 |
324 |
$7K |
| 80179 |
|
443 |
375 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
999 |
912 |
$7K |
| 80143 |
|
407 |
354 |
$6K |
| 82077 |
|
462 |
381 |
$6K |
| 94010 |
|
78 |
71 |
$6K |
| 90839 |
|
166 |
113 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
432 |
384 |
$4K |
| 97167 |
|
46 |
39 |
$3K |
| 94761 |
|
1,286 |
1,090 |
$3K |
| 84100 |
|
399 |
295 |
$2K |
| 82607 |
|
251 |
225 |
$2K |
| 71250 |
|
13 |
12 |
$2K |
| 92523 |
|
13 |
12 |
$2K |
| 85379 |
|
288 |
241 |
$2K |
| 85730 |
|
738 |
559 |
$2K |
| 84702 |
|
205 |
155 |
$1K |
| 87077 |
|
385 |
307 |
$1K |
| 84145 |
|
68 |
52 |
$1K |
| 83970 |
|
47 |
37 |
$990.46 |
| 73630 |
|
52 |
40 |
$870.42 |
| 82570 |
|
274 |
226 |
$787.95 |
| 82652 |
|
38 |
36 |
$759.39 |
| 84439 |
|
135 |
119 |
$732.75 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,670 |
1,321 |
$617.73 |
| 84550 |
|
250 |
212 |
$610.81 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
15 |
12 |
$575.64 |
| 84156 |
|
273 |
224 |
$574.91 |
| 82150 |
|
144 |
127 |
$539.91 |
| 87210 |
|
194 |
149 |
$377.24 |
| 97116 |
|
18 |
12 |
$365.51 |
| 87186 |
|
69 |
64 |
$361.20 |
| 73110 |
|
17 |
12 |
$343.44 |
| 88342 |
|
42 |
34 |
$321.90 |
| 96376 |
|
92 |
75 |
$317.40 |
| 83525 |
|
25 |
25 |
$177.84 |
| 84481 |
|
14 |
12 |
$165.83 |
| 84681 |
|
14 |
14 |
$162.21 |
| 86803 |
|
13 |
12 |
$143.26 |
| 82550 |
|
30 |
28 |
$99.80 |
| 87070 |
|
28 |
25 |
$97.25 |
| 82043 |
|
14 |
14 |
$43.61 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,419 |
6,100 |
$40.52 |
| 85045 |
|
16 |
13 |
$40.24 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
11,755 |
9,411 |
$31.67 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
469 |
265 |
$0.54 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
174 |
109 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,740 |
765 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
651 |
528 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
76 |
50 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
333 |
213 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
42 |
27 |
$0.00 |
| A9270 |
Non-covered item or service |
57 |
36 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
74 |
52 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
13 |
13 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
603 |
481 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
427 |
293 |
$0.00 |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
72 |
34 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
54 |
52 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
13 |
12 |
$0.00 |
| Q0239 |
Injection, bamlanivimab-xxxx, 700 mg |
36 |
34 |
$0.00 |